31st week of 2011 patent applcation highlights part 39 |
Patent application number | Title | Published |
20110189264 | Group of Nucleic Acid Fragments for Prevention of HIV Infection or AIDS and the Usage Thereof - The invention provides a group of nucleic acid fragments, shown in the sequence listing, for prevention of HIV infection or AIDS and the usage thereof. In the invention, a series of RNA fragments, which are highly homogenous to all the published HIV gene sequences, were obtained by homology compare. The double-stranded RNA (dsRNA) derived from these fragments can effectively inhibit the expression of the HIV genes. The RNA transcribed by plasmid, also can suppress the expression of the HIV in the cell. After the adenovirus or associated virus which carry DNA corresponding above RNA infect the cell, the transcription dsRNA can inhibit the expression of the HIV genes. | 2011-08-04 |
20110189265 | THERAPEUTIC USE OF NEW PHARMACEUTICAL PREPARATIONS CONTAINING ANTITUMORAL DRUGS BOUND TO HYALURONIC ACID IN THE TREATMENT OF NEOPLASIAS - The present invention describes the new use in the oncologic field of bioconjugates as differentiating agents obtained by the conjugation between hyaluronic acid (HA) and a chemotherapeutic product (identified hereafter with the trade-name ONCOFID®) among which, in particular, Irinotecan, Doxorubicin, Paclitaxel, Cis-platinum and 5-Fluorouracyl (5-FU) for treating primary tumors and metastasis. In particular, the biological behaviour is described in terms of action mechanism, efficacy and tolerability of pharmaceutical preparations of derivative of ONCOFID® soluble in water. More specifically, the invention relates to the surprising biological and pharmacological effect demonstrated by formulations based on ONCOFID-S (HA-SN38 conjugates) and ONCOFID-D (HA-Doxorubicin conjugates) in promoting the differentiation of tumoral cells towards a untransformed phenotype, compared with the reference drug Irinotecan (or CPT11 whose active form is represented by SN38) and Doxorubicin. | 2011-08-04 |
20110189266 | CORTICOSTEROID MICROVESICLES FOR TREATMENT OF CARDIOVASCULAR DISEASES - The invention provides a use of a long-circulating microvesicle comprising a sterol, partially synthetic or wholly synthetic vesicle-forming phospholipids, and a corticosteroid in water soluble form, which microvesicle has a mean particle diameter size range of between about 75 and 150 nm and which microvesicle is non-charged or negatively charged at physiological conditions, for the preparation of a medicament for the treatment of atherosclerosis and/or cardiovascular disease. A method for treating a subject suffering from, or at risk of suffering from, atherosclerosis and/or cardiovascular disease, comprising administering to said subject a therapeutically effective amount of such long-circulating microvesicles is also provided. | 2011-08-04 |
20110189267 | MULTIPLE CpG OLIGODEOXYNUCLEOTIDE AND THEIR USE TO INDUCE AN IMMUNE RESPONSE - Compositions including multiple oligodeoxynucleotides with a CpG motif are disclosed herein. The compositions can include either D or K type oligodeoxynucleotides. These compositions are of use in inducing an immune response in a large percentage of the individuals in a population. | 2011-08-04 |
20110189268 | Inhibition of Placenta Growth Factor (PLGF) Mediated Metastasis and/or Angiogenesis - The present invention concerns methods and compositions for inhibiting angiogenesis and/or tumor growth, survival and/or metastasis. In particular embodiments, the methods and compositions may concern ligands against placenta growth factor (PlGF), such as BP-1, BP-2, BP-3 or BP-4. Some methods may comprise administering one or more PlGF ligands, alone or in combination with one or more other agents, such as chemotherapeutic agents, other anti-angiogenic agents, immunotherapeutic agents or radioimmunotherapeutic agents to a subject. The PlGF ligands are effective to inhibit angiogenesis, tumor cell motility, tumor metastasis, tumor growth and/or tumor survival. In certain embodiments, PlGF ligands may be administered to subjects to ameliorate other angiogenesis related conditions, such as macular degeneration. In some embodiments, PlGF expression levels may be determined by any known method to select those patients most likely to respond to PlGF targeted therapies. | 2011-08-04 |
20110189269 | Extended release composition containing tramadol - The present invention relates to a once daily extended release pharmaceutical preparation of Tramadol or its acceptable pharmaceutical salts. | 2011-08-04 |
20110189270 | Differential Loading Of Drug-Eluting Medical Devices - A medical device includes a substrate having at least one surface. The surface has a central portion and a peripheral portion. At least one bioactive agent is disposed over at least a portion of the surface. The medical device having a concentration gradient of the at least one bioactive between the central and peripheral portions. | 2011-08-04 |
20110189271 | PHARMACEUTICAL FORMULATIONS OF ACID-LABILE DRUGS - Pharmaceutical formulations comprising inert cores that are coated with a layer comprising an amorphous dexlansoprazole sodium salt formed in-situ, further sequentially coated with an intermediate layer and an enteric coating layer. Coated cores may be further formulated to produce tablets or capsules. | 2011-08-04 |
20110189272 | PHARMACEUTICAL PREPARATION CONTAINING GABAPENTIN - A method for preparing a gabapentin granulate comprising melt granulating gabapentin with polyethylene glycol having a melting point comprised between 50 and 80° C. | 2011-08-04 |
20110189273 | AMANTADINE COMPOSITIONS AND METHODS OF USE - Methods of nighttime administration of amantadine to reduce sleep disturbances in patient undergoing treatment with amantadine are described, as well as compositions of extended release amantadine that are suitable for nighttime administration. | 2011-08-04 |
20110189274 | Stable Pharmaceutical Compositions Of Montelukast Or Its Salts Or Solvates Or Hydrates - A stable pharmaceutical composition includes a therapeutically effective amount of montelukast or its pharmaceutically acceptable salts, solvates or hydrates and a blend which includes microcrystalline cellulose and a flavoring agent and wherein said composition is substantially free of montelukast sulfoxide degradation product. A process for preparing such composition is also disclosed. | 2011-08-04 |
20110189275 | PTEROSTILBENE COCRYSTALS - Cocrystals of pterostilbene are disclosed, including: pterostilbene:caffeine cocrystal, pterostilbene:carbamazepine cocrystal, pterostilbene:glutaric acid cocrystal, and pterostilbene:piperazine cocrystal. The pterostilbene:caffeine cocrystal is polymorphic. Forms I and II of the pterostilbene:caffeine cocrystal are disclosed. The therapeutic uses of the pterostilbene cocrystals and of pharmaceutical/nutraceutical compositions containing them are also disclosed. The disclosure sets out various methods of making and characterizing the pterostilbene cocrystals. | 2011-08-04 |
20110189276 | PTEROSTILBENE COCRYSTALS - Cocrystals of pterostilbene are disclosed, including: pterostilbene:caffeine cocrystal, pterostilbene:carbamazepine cocrystal, pterostilbene:glutaric acid cocrystal, and pterostilbene:piperazine cocrystal. The pterostilbene:caffeine cocrystal is polymorphic. Forms I and II of the pterostilbene:caffeine cocrystal are disclosed. The therapeutic uses of the pterostilbene cocrystals and of pharmaceutical/nutraceutical compositions containing them are also disclosed. The disclosure sets out various methods of making and characterizing the pterostilbene cocrystals. | 2011-08-04 |
20110189277 | PTEROSTILBENE COCRYSTALS - Cocrystals of pterostilbene are disclosed, including: pterostilbene:caffeine cocrystal, pterostilbene:carbamazepine cocrystal, pterostilbene:glutaric acid cocrystal, and pterostilbene:piperazine cocrystal. The pterostilbene:caffeine cocrystal is polymorphic. Forms I and II of the pterostilbene:caffeine cocrystal are disclosed. The therapeutic uses of the pterostilbene cocrystals and of pharmaceutical/nutraceutical compositions containing them are also disclosed. The disclosure sets out various methods of making and characterizing the pterostilbene cocrystals. | 2011-08-04 |
20110189278 | PTEROSTILBENE COCRYSTALS - Cocrystals of pterostilbene are disclosed, including: pterostilbene:caffeine cocrystal, pterostilbene:carbamazepine cocrystal, pterostilbene:glutaric acid cocrystal, and pterostilbene:piperazine cocrystal. The pterostilbene:caffeine cocrystal is polymorphic. Forms I and II of the pterostilbene:caffeine cocrystal are disclosed. The therapeutic uses of the pterostilbene cocrystals and of pharmaceutical/nutraceutical compositions containing them are also disclosed. The disclosure sets out various methods of making and characterizing the pterostilbene cocrystals. | 2011-08-04 |
20110189279 | PHARMACEUTICAL COMPOSITIONS WITH MODIFIED RELEASE PROPERTIES COMPRISING 5-CHLORO-N-(-METHYL)-2-THIOPHENCARBOXAMID - The invention relates to pharmaceutical compositions with modified release properties comprising 5-Chloro-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid and process of preparing such compositions. | 2011-08-04 |
20110189280 | DOSAGE FORM COMPRISING 1-ISOPROPYL-4-HEXAHYDRO-1H-1,4-DIAZEPINE OR A SALT THEREOF - The invention relates to a dosage form for oral administration comprising a carrier tablet, wherein the carrier tablet is at least partially (preferably partially) covered by a film comprising 1-isopropyl-4-{[4-(tetrahydro-2H-pyran-4-yloxy)phenyl]carbonyl}hexahydro-1H-1,4-diazepine | 2011-08-04 |
20110189281 | TELMISARTAN AND HYDROCHLOROTHIAZIDE COMBINATION THERAPY - A pharmaceutical composition comprising about 80 mg of telmisartan or a salt thereof and about 25 mg of hydrochlorothiazide or about 160 mg of telmisartan or a salt thereof and about 50 mg of hydrochlorothiazide, and methods of treating hypertension in patients with such combination. | 2011-08-04 |
20110189282 | TABLET - The present invention can retain the volume of a tablet large without increasing the thickness of the tablet or the like dimension and prevents a plurality of tablets from sticking to each other even if they are subjected to a film-coating or the like treatment, so as to improve the yield. The tablet is a tablet ( | 2011-08-04 |
20110189283 | APPETISING MEDICAMENTS FOR ORAL ADMINISTRATION IN SOLID FORM FOR PREVENTION AND/OR TREATMENT OF CARDIAC INSUFFICIENCY IN ANIMALS - The invention relates to the use of a coating composition for application to a solid veterinary pharmaceutical composition for oral administration for the prevention and/or treatment of cardiac insufficiency in animals, by a method of film coating comprising a powder appetizing material, a binder and a solvent. The invention further relates to a coating method by film coating of solid veterinary pharmaceutical compositions for oral administration for the prevention and/or treatment of cardiac insufficiency in animals and appetizing medicaments for animals comprising a solid veterinary pharmaceutical composition for oral administration for the prevention and/or treatment of cardiac insufficiency in animals made from pimobendan and an appetizing coating arranged around said composition comprising an appetizing material and a binder. | 2011-08-04 |
20110189284 | Peptide Fibres - This invention relates to protein fibrils, to methods and kits of producing those protein fibrils comprising a plurality of first peptide monomer units arranged in a first strand and a plurality of second peptide monomer units arranged in a second strand in which said first and second strands form an overlapping staggered heterodimer coiled coil structure, and wherein the amino acid residues on the exposed surface of said first and second strands enable said protein fibril to interact with another protein fibril in a plurality of non-parallel orientations. This invention also relates to bundles of protein fibrils and matrices, in particular, hydrogels produced using those protein fibrils. | 2011-08-04 |
20110189285 | HYDROGEL CAPABLE OF CONTAINING AND CONVEYING CELLS - An interpenetrating biodegradable polymeric matrix hydrogel and the use thereof to support, encapsulate, convey and release several types of cells under conditions which allow the cells to be kept alive, grow and interconnect. The hydrogel may be used to prepare implants for integrally or partially regenerating, reconstructing and/or replacing damaged, dead or no longer functional tissues, in particular at the central nervous system or spinal marrow level. In such use, the biodegradability of the hydrogel allows a progressive release of the conveyed cells in order to promote their integration, even functional, with the surrounding tissue. The hydrogel may also be employed to support cells, for example, neural cells such as neuronal cells, on measuring devices, specifically realised for monitoring several parameters of cell activity, also during pharmacological and bio-mechanical tests. | 2011-08-04 |
20110189286 | Pulsatile Release of Valsartan - The present invention provides gastroretentive pulsatile pharmaceutical delivery systems that improve the bioavailability of Valsartan wherein the medicament has improved solubility, improved residence time in the gastrointestinal tract and a pulsatile release profile. | 2011-08-04 |
20110189287 | METHODS AND COMPOSITIONS FOR WOUND HEALING - The present invention relates to methods and compositions for wound healing. In particular, the present invention relates to promoting and enhancing wound healing by utilizing cross-linker covalent modification molecules to attach and deliver wound active agents to a wound. In addition, the present invention provides methods and compositions utilizing oppositely charged polyelectrolytes to form a polyelectrolyte layer on a wound surface. The invention further relates to incorporating wound active agents into a polyelectrolyte layer for delivery to a wound. | 2011-08-04 |
20110189288 | DIETHYLSTILBESTROL DOSAGE FORM AND METHODS OF TREATMENT - Oral dosage forms as a biodegradable, water soluble film for delivering pharmaceutically active agents, particularly diethylstilbestrol and pharmaceutically acceptable salts thereof to patients through insertion into the mouth of patient and methods for administering pharmaceutically active agents to patients by insertion into the mouth to provide selective uptake of said agents through the mucosa and thus avoiding the gastrointestinal tract. | 2011-08-04 |
20110189289 | Cell-Based Method and Means for Rebuilding Bone - The invention relates to the use of in vitro isolated or in vitro differentiated osteoclasts for bone rebuilding, in particular by in vivo application, to trigger bone rebuilding by attracting osteoblasts and preferably also vascular cells to sites of bone defect. It has been found by the inventors that osteoclasts can control bone rebuilding by secreting chemotactic factors and attracting osteoblasts and vascular cells to a site of bone defect. The invention further relates to the use of osteoclasts for the manufacture of a pharmaceutical preparation or medical product containing osteoclasts for the use for bone rebuilding. | 2011-08-04 |
20110189290 | Compositions Comprising Capture Peptides for A B-Amyloid Peptide - Disclosed herein is a composition for the treatment and/or prevention of Alzheimer's disease and the delivery thereof. The composition comprises a PEG hydrogel having bound thereto a capture peptide, wherein the capture peptide is capable of binding beta-amyloid. In another embodiment, the capture peptide is attached to a solid support. | 2011-08-04 |
20110189291 | DENDRIMER HYDROGELS - Photoactivatable dendrimers and hydrogels formed therefrom include dendrimers to which polymer chains (e.g. polyethylene glycol, PEG) have been conjugated; and reactive photoactivatable groups attached to terminal functional groups of the polymer chains (e.g. hydroxyls of PEG). Exposure to a suitable wavelength of light activates the photoactivatable groups, which then crosslink with one another, thereby forming a hydrogel. The hydrogel may also include one or more agents of interest; or, in some embodiments, nanoparticles containing one or more agents of interest may be dispersed in the hydrogel. These formulations are well-suited for sustained or prolonged delivery of active agents, e.g. for the treatment of glaucoma by the sustained delivery of anti-glaucoma agents directly to the eye. | 2011-08-04 |
20110189292 | DERMAL FILLERS COMPRISING SILK FIBROIN HYDROGELS AND USES THEREOF - The present specification provides compositions useful as dermal fillers and methods using such compositions to treat a condition of skin. | 2011-08-04 |
20110189293 | THERAPEUTIC REGIMENS FOR THE TREATMENT OF IMMUNOINFLAMMATORY DISORDERS - A method for treating an immunoinflammatory disorder in a subject in need thereof, said method comprising administering to said subject a unit dosage form comprising dipyridamole coated onto acid beads and formulated for controlled release. The method further including administering a corticosteriod concurrently with administration of the dipyridamole. | 2011-08-04 |
20110189294 | PESTICIDAL COMPOSITIONS - A formulated composition suitable for controlling or preventing pathogenic damage in a plant comprising (A) at least one solid active ingredient having a water solubility of at most 100 μg/litre at 25° C. at neutral pH, in an amount of at least 1 weight %, based on the total weight of the formulated composition, (B) at least one non-ionic surface active compound having a hydrophile-lipophile balance (HLB) of between 10 and 18, one or more customary formulation auxiliaries, and water; wherein active ingredient (A) is suspended or dispersed in the water, the weight ratio of surface active compound (B) to active ingredient (A) is in the range of from 1.5 to 15.0, provided the minimum amount of surface active compound (B) is at least 6 weight %, based on the total weight of the formulated composition. Also a method of improving pesticide residue levels in agriculture. | 2011-08-04 |
20110189295 | TELMISARTAN TABLETS - A composition containing the active substance telmisartan, which consists of granules of a telmisartan mixture, in which there is the active substance in the form of alkali salts, further contained is an organic or inorganic base selected from meglumine, sodium or potassium hydroxide, or a mixture of said bases, a binder, most preferably polyvinylpyrrolidone, sorbitol, and optionally other auxiliary substances; the composition further containing, outside the granules, particles of sorbitol, and optionally of other auxiliary substance, the size of 99% by\ weight of all particles of the telmisartan mixture being smaller than 1.0 mm and the size of 95% by weight of all particles of sorbitol contained in the composition inside as well as outside the granules of the telmisartan mixture being within the range of 0 to 0.250 mm. | 2011-08-04 |
20110189296 | BONE SUBSTITUTE CONTAINING POROUS BIO-GLASS AND CALCIUM SULPHATE - The invention relates to a composition for a bone substitute that includes powdery or populated porous bio-glass and powdery alpha hemihydrate calcium sulphate. The invention also relates to an injectable composition for forming a bone substitute that includes said composition of powdery or granulated porous bio-glass and powdery alpha hemihydrate calcium sulphate, with 10 to 50 wt % of added water. | 2011-08-04 |
20110189297 | STABLE SOLID ORAL DOSAGE CO-FORMULATIONS - Pharmaceutical compositions are provided that can act as boosters to improve the pharmacokinetics of drugs that undergo in vivo degradation by cytochrome P450 enzymes. Methods of inhibiting cytochrome P450 enzymes are provided that can be used for improving the treatment of diseases by preventing degradation of drugs or other molecules by cytochrome P450. Specifically, methods of inhibiting metabolic degradation of atazanavir sulphate for administering to a patient suffering from HIV infection are disclosed. | 2011-08-04 |
20110189298 | DOUBLE EMULSION AND METHOD TO PRODUCE SUCH - The invention is directed to a method to produce a water-in-oil-in-water (w/o/w) emulsion, comprising: a. preparing a water-in-oil (w/o) emulsion; b. atomizing said w/o emulsion in the presence of a carrier material comprising at least a water soluble matrix material and at least one emulsifier, to form agglomerates; c. dispersing said agglomerates in an aqueous liquid, such as water or an aqueous solution. Also provided is a new instant powder (obtained after step b) that can be used to prepare the w/o/w emulsion. The emulsion of the invention is advantageously suited for the encapsulation of active components. | 2011-08-04 |
20110189299 | PHARMACEUTICAL COMPOSITION CONTAINING SURFACE-COATED MICROPARTICLES - The invention provides a pharmaceutical composition that can be used for efficient administration of low-molecular weight drugs and polymeric compounds such as peptides and proteins by methods other than injection, as well as a method for producing the composition. The pharmaceutical composition is for transmucosal administration and comprises (a) a drug having a positive or negative charge at a predetermined pH, (b) a pharmaceutically acceptable small particle and (c) a pharmaceutically acceptable surface-coating polymer capable of being electrically charged at the pH, wherein the surface of the small particle is coated by the surface-coating polymer, the drug is immobilized on the surface of the small particle via the surface-coating polymer, and a complex is formed by a noncovalent interaction between the small particle and the surface-coating polymer and a concurrent electrostatic interaction between the surface-coating polymer and the drug. | 2011-08-04 |
20110189300 | siRNA SILENCING OF APOLIPOPROTEIN B - The present invention provides nucleic acid-lipid particles comprising siRNA molecules that silence ApoB expression and methods of using such nucleic acid-lipid particles to silence ApoB expression. | 2011-08-04 |
20110189301 | METHOD FOR PREPARING CONTACT LENS-SHAPED AMNIOTIC DRESSING - The present invention relates to a method for preparing a contact lens-shaped amniotic dressing and a contact lens-shaped amniotic dressing prepared therefrom for treating ocular surface diseases, which does not require the use of sutures or an adhesion material. The inventive contact lens-shaped amniotic dressing is capable of solving the problems associated with suturing an amniotic membrane, e.g., highly delicate surgical techniques of suturing, long surgery time, stitch abscess, granuloma formation, tissue necrosis, and discomfort of patients; and the problems associated with the use of a support, e.g., the elimination of the support by eye blinking, breaking of the support, and discomfort. | 2011-08-04 |
20110189302 | ELECTROCHEMICAL DEVICE - There is provided an automated electrochemical device for generating a biocidal output solution, said device comprising: a flow-through electrochemical cell comprising an anodic chamber and a cathodic chamber for electrolysing an electrolyte to generate an anolyte solution and a catholyte solution; characterised in that the device further comprises: (i) a reservoir for storing catholyte; and (ii) a hydraulic circuit for recirculating catholyte from the reservoir to the anolyte on start-up of the cell, wherein input of catholyte of a compensating strength to the cell anodic chamber, is arranged so as to optimise the cell anolyte pH to produce a stable output solution at the start of the electrolysis process. | 2011-08-04 |
20110189303 | METHODS FOR ENHANCING THE QUALITY OF LIFE OF A SENIOR ANIMAL - The present invention relates to methods for enhancing the quality of life of a senior or super senior animal by feeding the animal a composition comprising at least one omega-3 polyunsaturated fatty acid and various combinations of amino acids, minerals, and antioxidants in amounts effective to enhance alertness, improve vitality, protect cartilage, maintain muscle mass, enhance digestibility, and improve skin and pelage quality. Beneficial changes in expression of genes associated with several biological pathways may be induced in an animal by feeding it said composition and are consistent with an enhancement in the quality of life of said animal. | 2011-08-04 |
20110189304 | ABSORBABLE IMPLANTS AND METHODS FOR THEIR USE IN HEMOSTASIS AND IN THE TREATMENT OF OSSEOUS DEFECTS - The present invention relates to mechanically hemostatic body-absorbable compositions having a putty-like consistency. The compositions preferably comprise a finely powdered, carboxylic acid salt and a liquid block copolymer of ethylene oxide and propylene oxide. | 2011-08-04 |
20110189305 | TREATMENT OF LUNG CANCER - An immunomodulatory compound is administered to treat, prevent, inhibit, or reduce lung cancer in a subject. | 2011-08-04 |
20110189306 | COMPOUNDS, COMPOSITIONS AND TREATMENTS FOR V-ATPase RELATED DISEASES - The present invention relates to therapeutic and/or prophylactic uses of hydrazide compounds and to pharmaceutical compositions containing one or more of these compounds as an active component for treating a disease or disorder requiring modulation of vacuolar (H+)-ATPases. | 2011-08-04 |
20110189307 | METHODS AND COMPOSITIONS FOR OXYGENATION OF SKIN TO TREAT SKIN DISORDERS - Methods and compositions for treating wounds, decubitus ulcers, diaper rash, burns, abrasions, and other irritations and relevant injuries are provided. The invention contemplates in one embodiment the use of an aqueous or emollient medium having one or more pH raising ingredients in a composition specifically designed to deliver oxygen to the skin's surface. | 2011-08-04 |
20110189308 | METHODS TO TREAT NEURODEGENERATIVE CONDITIONS OR DISEASES BY TARGETING COMPONENTS OF A PTEN SIGNALING PATHWAY - The disclosure provides that components of a PTEN cell signaling pathway may be utilized as therapeutic targets for treating, preventing, slowing the progression of or delaying the onset of a neurodegenerative disease or disorder. Such components that may be targeted include, phosphatase and tensin homologue (PTEN), glycogen synthase kinase 3 beta (GSK3β), and AKT. The subject matter disclosed herein relates to the therapeutic use of inhibitors of PTEN, inhibitors of GSK3β, or activators of AKT to treat a neurodegenerative disease or disorder in a subject. Compounds are disclosed which may be used in the methods provided. | 2011-08-04 |
20110189309 | TOPICAL MEDICAMENT - The present invention relates, in general, to topical medicinal formulations that provide pain relief and enhance recovery from injury. In particular, the invention relates to a topical medicinal formulation comprising 0.35 to 35% of a soluble salt of a biologically acceptable alkali metal or alkaline earth metal such as sodium, potassium, lithium, magnesium and calcium and their use in methods of treating pain or enhancing healing. | 2011-08-04 |
20110189310 | SMALL MOLECULE MODULATORS OF PRONGF UPTAKE - The present invention relates to a method of inhibiting cellular uptake of pro-nerve growth factor (proNGF) in a cell expressing neurotrophin p75 receptor in a mammal in need thereof. Such mammals include, for example, those suffering from neuropathological conditions. In another aspect, the invention relates to a method of promoting cellular uptake of proNGF in a cell expressing p75 | 2011-08-04 |
20110189311 | Highly Absorbable Drug Composition and Method of Producing the Same - Provided is a highly absorbable drug composition including one or more water-soluble compound (A) selected from an enzyme-treated hesperidin, a stevia extract, or an enzyme-treated stevia and a poorly water-soluble drug (B) selected from flurbiprofen or probucol. | 2011-08-04 |
20110189312 | Compositions and Methods for Supporting Heat Shock Protein Function - Compositions and methods for promoting or maintaining protein accretion in cells, particularly in skeletal muscle cells, by supporting heat shock protein function. The compositions comprise glutamine and additional components directed at enhancing the activity of heat shock proteins. | 2011-08-04 |
20110189313 | Method of using a green coffee bean extract to promote carnitine palmitoyltransferase activity - (Problems) To provide a highly safe dietetic composition originating in green coffee beans by which excellent dietetic effects can be obtained and which contributes to the prevention and treatment of life style-related diseases such as diabetes. | 2011-08-04 |
20110189314 | NATURAL PRESERVATIVE ALTERNATIVES AND COMPOSITIONS CONTAINING SAME - A cosmetic preservative is disclosed which comprises | 2011-08-04 |
20110189315 | PLANT EXTRACT AND PUFA COMBINATIONS - The present invention relates to the combination of a plant extract, such as oregano extract and a polyunsaturated fatty acid or a derivative (such as an ethyl ester “PUFA EE”) which is stable under strorage conditions. | 2011-08-04 |
20110189316 | COMPOSITION FOR CONTROLLING INCREASE IN BLOOD GLUCOSE - The present application describes a composition for blood glucose control containing green tea extracts (GTE) with gallated catechins (GC) and macromolecule to prevent the intestinal absorption of GC. | 2011-08-04 |
20110189317 | Method for Inhibiting the Activity of DPP-IV and Lowering Blood Glucose Level - The present invention relates to a method for inhibiting the activity of dipeptidyl peptidase-IV (DPP-IV) and decreasing blood glucose levels. | 2011-08-04 |
20110189318 | METHODS FOR ENHANCING THE EXPRESSION OF INTRACELLULAR REDOX-ASSOCIATED FACTORS - The present invention provides methods for enhancing expression of a redox-associated factor, wherein kaempferol, quercetin or glycosides thereof, or any combination thereof is used as an active ingredient, and methods for enhancing expression of a redox-associated factor wherein ginkgo leaf extract, | 2011-08-04 |
20110189319 | Lifeforce liquid supplement - Two very important factors in human life—which play vital roles in promoting well being—includes returning the body to homeostasis and giving boost to body called lifeforce to get overall health free from diseases, i.e., its optimal balanced functioning ability. When the body is at homeostasis, there is no place for disease. It is only when the body is out of balance (something is deficient, in excess or stagnating) that pain, illness or disease can occur. The application described is based on returning the body to homeostasis (removing the problem and balancing the body) by providing lifeforce and not on dealing with the symptom (e.g., pain, vitamin deficiency). Imbalance results in various diseases and adverse health conditions (starting from aging to diabetes and cancers). This wonderful composition will interact with the body in a way that allows it to boost lifeforce and reach homeostasis no matter which direction it was. In this combination, in the form of liquid, all the 14 ingredients ( | 2011-08-04 |
20110189320 | EDIBLE OLIVE POMACE OIL CONCENTRATED IN TRITERPENIC ACIDS, PROCEDURE OF PHYSICAL REFINING UTILISED FOR OBTAINMENT THEREOF AND RECOVERY OF FUNCTIONAL COMPONENTS PRESENT IN THE CRUDE OIL - Procedure of refining crude olive pomace oil obtained through centrifuging or decantation of the pomace, comprising the stage of filtration of the starting crude olive pomace oil carried out through filters having a pore size comprised in the interval from 0.1 to 20 microns and at a temperature below 70° C., preferentially between 35 and 45° C. | 2011-08-04 |
20110189321 | MEDICINAL AGENT EXHIBITING ANTIPROTOZOAL ACTIVITY TO TRICHOMONAS VAGINALIS IN AN IN-VITRO MODEL SYSTEM - The invention belongs in the field of medicine and can be used in the treatment of chronic and asymptomatic trichomonas infections of the urogenital tract. | 2011-08-04 |
20110189322 | COMPOSITIONS COMPRISING DOCYNIA DELAVAJY EXTRACT AND/OR ELAEAGNUS LANCELOTUS EXTRACT - Disclosed are compositions that include | 2011-08-04 |
20110189323 | COSMETIC COMPOSITIONS - There is disclosed a skincare composition suitable for topical application to the skin. The composition comprises two or more active ingredients selected from the group consisting of a) dipalmitoyl hydroxyproline, salts and esters thereof; b) carnitine; and c) an extract of | 2011-08-04 |
20110189324 | POST CURE INFLATOR - A post cure inflator of the present invention is an apparatus for inflating and cooling a vulcanized tire T by sealing high pressure air into the vulcanized tire, and includes an annular rim for gripping the vulcanized tire at a bead portion, a connecting member fixed at one end portion thereof to the rim, a rim supporting member provided in a body frame, and a clamping device provided in the rim supporting member to clamp the connecting member to the rim supporting member unclampably. This construction permits a post cure inflator in which replacement of the rim is easy and an existing rim can be used. | 2011-08-04 |
20110189325 | Process and technical arrangement to produce in series single crystal penetrator rods of an alloy of 40wt% tungsten-40wt% titanium-20wt% osmium to replace depleted uranium which causes after use hazardous environmental problems - A new process and technical arrangement to produce in series penetrator rods which have a true single crystal structure consisting of an alloy of 40% by weight Tungsten, 40% by weight Titanium, 20% by weight Osmium. Those single crystal penetrator rods do not break up upon impact on a target, the material sleeves back over the surface whilst the core drives forward and penetrates till the given velocity is used up. This phenomena is only achievable with a single crystal structure and leads to a size and weight reduction because there is not any material lost upon impact on the target as it happens with all penetrator rods which have a grain structure and as they are used today. This alloy as named above has the highest density and highest hardness possible, caused by the crystal growth process and it permits the user to stay out of reach of any opponent not using the same material. | 2011-08-04 |
20110189326 | SUNSHADE WITH ADJUSTABLE SLIDE PORTION - A sunshade for a vehicle having a first guide and a second guide spaced from the first guide. The sunshade has a pair of edges and includes a substrate layer and an aesthetic layer fixed to the substrate layer to present a show surface. Slide portions are disposed along each of the edges and are adapted to move within the first and second guides as the sunshade moves between an open position and a closed position. The slide portions define a generally corrugated configuration to provide a force that must be overcome to move the sunshade between the open position and the closed position. | 2011-08-04 |
20110189327 | MOLDING MACHINE - A molding machine includes a plurality of operating die units that are arranged in series while die opening/closing directions of the operating die units are respectively matched with each other. The operating die units can be closed and opened by a common drive source. The molding machine may further include a plurality of replacement die units that are respectively positioned adjacent to the operating die units and are arranged in a direction perpendicular to the die opening/closing directions of the operating die units, and support bases that are capable of moving the replacement die units to die operating positions in which the replacement die units can be closed and opened by the drive source. The support bases are capable of moving the operating die units in the direction perpendicular to the die opening/closing directions thereof and to shift the same in positions different from original positions of the replacement die units. | 2011-08-04 |
20110189328 | PRINTING MOLD FOR NANOIMPRINT LITHOGRAPHY DEVICE - A nanoimprint lithography device includes a base, a pair of opposite rotator formed on the base, and a printing mold connected to the rotators. The printing mold includes a cylindrical main body having a nanometer-scale pattern formed thereon and a pair of connecting piece detachably connected to the main body. The printing mold is connected to the rotators via the connecting pieces and is configured to be driven by the rotators to print the nanometer-scale pattern on a substrate. | 2011-08-04 |
20110189329 | Ultra-Compliant Nanoimprint Lithography Template - An ultra-compliant nanoimprint lithography template having a backing layer and a nanopatterned layer adhered to the backing layer. The nanopatterned layer includes nanoscale features formed by solidifying a polymerizable material in contact with a mold. The polymerizable material includes a fluoroelastomer and a photoinitiator. The backing layer has a higher elastic modulus than the nanopatterned layer. The ultra-compliant nanoimprint lithography template can be used to form multiple high fidelity imprints. | 2011-08-04 |
20110189330 | METHOD AND APPARATUS FOR MANUFACTURING PNEUMATIC TYRES - A green tyre disposed on a toroidal support is introduced into a vulcanisation mould. The mould is closed through axial approaching of a pair of sidewall plates acting against the sidewalls of the tyre. Circumferential sectors set to operate against the tyre tread band are maintained spaced apart from the tread band itself during admission of a working fluid designed to press the tyre against the toroidal support. Subsequently, the sectors are centripetally approached for penetration into the tread band concurrently with a step of full moulding and vulcanisation of the tyre carried out through admission of steam under pressure into the tyre itself. | 2011-08-04 |
20110189331 | METHOD FOR PRODUCING HOLLOW BODIES FROM THERMOPLASTIC MATERIAL, AND DEVICE FOR PRODUCING HOLLOW BODIES FROM THERMOPLASTIC MATERIAL - The invention relates to a device for producing hollow bodies from thermoplastic material in which web- or strip-type preforms of plasticised plastics material are shaped in a multi-part tool which forms a mould nest, with two outer moulds and a central mould which perform opening and closing movements with respect to one another. The central mould is provided with at least one device for receiving and manipulating components to be fastened in the interior of the hollow body by means of a material and/or form-fitting joint. Prior to the fastening of the components to the inner wall of the hollow body to be produced, the components are heated by means of a radiant heating device. The radiant heating device is advantageously integrated in the central mould of the tool. | 2011-08-04 |
20110189332 | AIR CARTRIDGE DEVICES AND METHODS OF USING SAME - Air cartridge devices and methods of using the air cartridge devices are provided. In an embodiment, the present disclosure provides an air cartridge device comprising an elongated cylindrical shaft defining a first elongated end portion and a second elongated end portion. The second elongated end portion can defining one or more apertures. The air cartridge device can be incorporated into a blow molding apparatus for blow molding bottles. | 2011-08-04 |
20110189333 | INJECTION MOULDING MACHINE AND HYDRAULIC UNIT FOR THIS - Injection moulding machine comprising
| 2011-08-04 |
20110189334 | INJECTION MOLD - An injection mold for insert molding includes a stationary plate, a first core and a second core. The stationary plate defines an upper surface and a side surface perpendicular to the upper surface. The upper surface has a slot at a middle portion thereof. The slot extends perpendicular to the side surface and reaches the side surface. The first core is received in the slot of the stationary plate and defines a holding element on a top surface thereof for securing an insert. The second core is closed with the first core to form a mold cavity, with the insert extending into the mold cavity. The first core is capable of being taken off from the slot of the stationary plate when the first core and the second core are detached from each other. | 2011-08-04 |
20110189335 | ANIMAL ATTRACTANT - There is provided animal attractants and in particular attractants for enhancing the attractiveness of food substances for consumption by a target animal, such as pet cats and dogs. The attractant is in the form of a sprayable liquid having organoleptic properties and that can be selectively dispensed onto the surface of or within a substance such as a food substance, to stimulate one or both of the smell and/or taste senses of a target animal to encourage the animal to consume the substance. The attractant comprises an oil or substantially wholly oil carrier in which is an olfactory and/or flavoring. The attractant may also be used to encourage the consumption of substances such as medicines, food supplements and dietetic preparations. | 2011-08-04 |
20110189336 | Health Beverages Comprising Cinnamon Extract and Methods of Making and Using The Same - Described herein are beverages that provide a number of heath benefits associated with elevated or high blood sugar levels. For example, the beverages are useful in potentiating insulin activity, treating hyperglycemia, and maintaining blood sugar levels in a subject afflicted with diabetes. The beverages are composed of distilled water, cinnamon extract, and sweetener. Vitamins, minerals, and nutrients can be added to the beverage to provide additional health benefits. | 2011-08-04 |
20110189337 | COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF METABOLIC DISEASES - The present invention is a new method and composition that enhance bone repair, formation, maintenance and slowing of bone resorption. The present invention relates to methods and compositions that enhance collagen formation, tendon health and tendon injury healing, bone maintenance and bone injury healing, and the prevention and treatment of metabolic diseases. The present invention is a part of the therapy to maintain bone health among patients with diabetic bone resorption and others with metabolic disorders. In one embodiment, the composition is a composite of hydroxyapatite and an organic matrix composed of milk pH-dependent serum proteins, i.e., bone morphogenic proteins (BMP), milk serum-derived specific proteins (MSSP), and milk serum derived proteins. | 2011-08-04 |
20110189338 | MICROBIOCIDAL CONTROL IN THE PROCESSING OF MEAT-PRODUCING FOUR-LEGGED ANIMALS - Methods of processing four-legged slaughter animals for consumption as meat and/or meat product(s) are described. The methods comprise I) contacting exterior surfaces of the live animal at least once with a microbiocidal solution formed from mixing together at least (i) water and (ii) at least one 1,3-dibromo-5,5-dialkylhydantoin, such contacting occurring at least once when the animal is en route to being slaughtered but before it is killed by exsanguination; or II) contacting the carcass of the animal, after exsanguination, with a microbiocidal solution formed from mixing together at least (i) water and (ii) at least one 1,3-dibromo-5,5-dialkylhydantoin or III) contacting at least one to raw meat product and/or at least one processed meat product derived from the carcass. | 2011-08-04 |
20110189339 | GENES FOR PLANT FATTY ACID MODIFYING ENZYMES ASSOCIATED WITH CONJUGATED DOUBLE BOND FORMATION - The preparation and use of nucleic acid fragments encoding plant fatty acid modifying enzymes associated with conjugated double bond formation or functionally equivalent subfragments thereof are disclosed. Chimeric genes incorporating such nucleic acid fragments or functionally equivalent subfragments thereof or complement thereof and suitable regulatory sequences can be used to create transgenic plants having altered lipid profiles. | 2011-08-04 |
20110189340 | SPARKLING ALCOHOLIC BEVERAGE, AND METHOD FOR PRODUCTION THEREOF - Provided is a method of manufacturing a sparkling alcoholic beverage excellent in properties such as flavor without using hops as part of raw materials. The method of manufacturing a sparkling alcoholic beverage includes: a pre-fermentation step ( | 2011-08-04 |
20110189341 | Soluble Oat Or Barley Flour And Method Of Making Utilizing Enzymes - Producing soluble oat or barley flour by using enzymes to precondition whole oat or barley flour prior to an extrusion (continuous cooking) process. | 2011-08-04 |
20110189342 | HIGH-PURITY GALACTOOLIGOSACCHARIDES AND USES THEREOF - Disclosed herein are high-purity galactooligosaccharide compositions, methods of producing high-purity galactooligosaccharides, food products and method of preparing food products comprising a high-purity galactooligosaccharide composition. | 2011-08-04 |
20110189343 | NANO-SIZED LACTIC ACID BACTERIA - Cells of lactic acid bacteria, which have been obtained by controlling pHs of media in a culturing step and processing steps to a neutral range of, for example, from 5 to 8 or so, have a mode value (particle size) of 1.0 μm or smaller in their particle size distribution. Cells of nano-sized lactic acid bacteria which have such a small particle size are excellent in INF-α producing capacity and are also superb in water dispersibility. | 2011-08-04 |
20110189344 | RECOVERY OF INSOLUBLE ENZYME FROM FERMENTATION BROTH AND FORMULATION OF INSOLUBLE ENZYME - Methods are provided for recovery and formulation of insoluble enzymes from a microbial fermentation broth, without removal of microbial cells or cell debris. Granular and liquid formulations comprising insoluble enzymes are also provided. | 2011-08-04 |
20110189345 | OILY MIXTURE OF NATURAL BIOACTIVE INGREDIENTS TO PREPARE AN ENRICHED FOOD PRODUCT - The present invention provides an oily mixture based on natural bioactive ingredients to be used to prepare an enriched food product that includes salmon oil enriched with EPA and DHA, alpha-tocopherol and supercritical rosemary extract. Optionally, this mixture can contain the microalga | 2011-08-04 |
20110189346 | USE OF ALTERNAN AS INGREDIENT FOR CERTAIN FOODSTUFFS - The invention is directed to the use of an alternan as an ingredient for acidic foodstuffs and to an acidic foodstuff comprising alternan as ingredient. The invention is also directed to the use of alternan as a heat stable ingredient in a foodstuff formulation, and to a foodstuff comprising alternan as ingredient, wherein the foodstuff was subjected to a heating step during its manufacture. | 2011-08-04 |
20110189347 | USE OF SUCCINIC ACID - This invention relates to a composition comprising Succinic Acid or a derivative thereof. It has been surprisingly found that Succinic Acid and derivatives thereof have a great potential for use in animal feed, e.g. for improving the feed conversion ratio (FCR) and/or for modulation of the gut flora. It is therefore the main object of the present invention to provide compositions and methods for the use of Succinic Acid in animal feed. | 2011-08-04 |
20110189348 | COMPOSITIONS CONTAINING SUCRALOSE AND APPLICATION THEREOF - Novel utilization of sucralose which is a high intense sweetener. Compositions containing sucralose including: sweetening compositions having excellent sweetness qualities based on the characteristics of sucralose; foods with a masked unpleasant smell and unpleasant taste; performance food compositions (viscous food compositions, gel food compositions, emulsified food compositions); foods with improved flavors; preservatives and foods with improved quality of taste; and flavor compositions with improved flavors. Novel utilization of sucralose as a sweetener improver, a masking agent for unpleasant smell/unpleasant taste, a flavor improver, a function improver (viscosity, gelling properties, emulsification properties), a taste characteristic improver, and a flavor improver/enhancer. | 2011-08-04 |
20110189349 | Fat soluble vitamin fed supplements and processes for delivering same - A process is disclosed for delivering a stable, fat soluble vitamin to a feed composition. The process includes dissolving a fat soluble vitamin in a solvent to form a vitamin-enriched solvent and combining the vitamin-enriched feeds; processes for supplementing the diet of a feed animal with a fat soluble vitamin, processes for extending the shelf life of an animal product, and processes for making stable vitamin-enriched supplements for feed compositions are also provided. | 2011-08-04 |
20110189350 | CAPSULE, DEVICE, AND METHOD FOR PREPARING INFUSED BEVERAGES - The present invention relates to a capsule | 2011-08-04 |
20110189351 | FAT BLOOM INHIBITING FOOD COMPOSITIONS AND METHODS - Shelf stable non-refrigerated food products having base-cake, filling and coating components with fat bloom inhibiting characteristics and low fat migration. One embodiment provides a food composition having a base-cake having canola oil and having moisture content in a range of about 1.7 to 3.1 percent; a créme filling having a non-lauric fat, and having a water activity level of about 25; and a coating having lauric fat and a non-lauric fat, and having less than about 1 percent moisture. | 2011-08-04 |
20110189352 | Convenience Desert Item and Method of Preparation and Use - A convenience desert item wherein the container is filled with portions of the desert item, which are first prepared outside the container, cut into multiple portions, and placed into the container in layers, each layer is comprised of a plurality of the cut portions, which are gently compressed before placing additional layers on top of said layer, and the final layer having a frosting applied to the top of the final layer; a method of preparing, storing, transporting, and serving a desert item, comprising the steps of preparing a desert, reducing the desert into a plurality of portions, providing a container, said container having a handle, providing a lid adapted to close the container, placing one or more of the portions into the container to create a first layer of portions, compressing the first layer of portions located in the container, placing additional one or more portions into the container to form a second layer of portions, compressing the second layer of portions located in the container, smoothing a top surface of a top layer of portions, placing the lid on the container, freezing the container and/or storing the container, grasping the handle of the container, transporting the container from a first location to a second location while grasping the handle, removing the lid from the container, scooping downwardly into the container, through more than one layer with a utensil to remove a serving portion, placing the serving portion onto a plate, and replacing the lid onto the container. | 2011-08-04 |
20110189353 | Methods of Flavor Encapsulation and Matrix-Assisted Concentration of Aqueous Foods and Products Produced Therefrom - Flavor encapsulation is generally performed by mixing flavor with a prolamin solution and drying the mixture into powdered forms of encapsulated flavor. In one embodiment, flavor and zein are separately dispersed in an alcohol-water mixture of appropriate ratio prior to mixing. In another embodiment, an aqueous food comprising bioactive components is mixed with the prolamin solution, thereby initiating precipitation of the prolamin and concentration of the bioactive components in said aqueous food. Resulting powdered forms of encapsulated flavor comprise the bioactive components from the aqueous food. In another embodiment, a two-phase drying process may be employed comprising removal of alcohol for evaporation-induced-self-assembly of zein microstructures, followed by removal of remaining water to produce said powdered form. | 2011-08-04 |
20110189354 | METHOD AND APPARATUS FOR AN UPRIGHT FOOD HOLDER - The present invention discloses an apparatus and method for consuming a wrapped food item in a non-dining or informal dining environment. The method comprises placing the wrapped food item into an upright food holder, removing one or more portions of the upright food holder during a process of consuming the to wrapped food item, wherein the wrapped food item comprises a substantially cylindrical shape. In one embodiment, the upright food holder comprises a tapered cup designed such that portions of the tapered cup are removed during a process of consuming the wrapped food item. Methods for removing portions of the upright food holder comprise string, tape, and perforations. The wrapped food items may be burritos, wraps, shawarmas, gyros, falafels, and special shaped sandwiches. | 2011-08-04 |
20110189355 | THERMOPLASTIC TRAY - A solid thermoformed plastic tray ( | 2011-08-04 |
20110189356 | Methods of Storing Cheese - One aspect of the present invention relates to a package for respiring foodstuffs, such as bloomy rind cheese products, with improved shelf life. In certain embodiments the package comprises a bloomy rind cheese enclosed in thermoplastic film having a carbon dioxide transmission rate of about 10,000 cc/100 sq.in/day, oxygen transmission rate of about 1,100 cc/100 sq.in/day, and water vapor transmission rate of about 26.6 g/100 sq.in/day at 100 F/90% RH. In certain embodiments the package comprises a bloomy rind cheese enclosed in thermoplastic film having a carbon dioxide transmission rate of about 8,240 cc/100 sq.in/day, oxygen transmission rate of about 1,030 cc/100 sq.in/day, and water vapor transmission rate of about 19.1 g/100 sq.in/day at 100 F/90% RH. The present invention also relates to a method for wrapping a respiring food product with a thermoplastic film having a carbon dioxide transmission rate of about 10,000 cc/100 sq.in/day, oxygen transmission rate of about 1,100 cc/100 sq.in/day, and water vapor transmission rate of about 26.6 g/100 sq.in/day at 100 F/90% RH. The present invention also relates to a method for wrapping a respiring food product with a thermoplastic film having a carbon dioxide transmission rate of about 8,240 cc/100 sq.in/day, oxygen transmission rate of about 1,030 cc/100 sq.in/day, and water vapor transmission rate of about 19.1 g/100 sq.in/day at 100 F/90% RH. | 2011-08-04 |
20110189357 | BLENDER WITH FEATURE FOR DISPENSING PRODUCT BY WEIGHT - Disclosed herein is an apparatus for preparing frozen drinks. The apparatus comprises a platform configured to support a blender cup, the platform reversibly translatable between a first position beneath an ice shaver and a second position beneath a flavoring dispenser and a weight sensor mechanically coupled to the platform and configured to produce an output indicative of a weight of an object present on the platform. | 2011-08-04 |
20110189358 | BLENDER WITH FEATURE FOR DISPENSING PRODUCT BY WEIGHT - Disclosed herein is an apparatus for preparing frozen drinks. The apparatus comprises a platform configured to support a blender cup, the platform reversibly translatable between a first position beneath an ice shaver and a second position beneath a flavoring dispenser and a weight sensor mechanically coupled to the platform and configured to produce an output indicative of a weight of an object present on the platform. | 2011-08-04 |
20110189359 | METHOD FOR REDUCING THE PULP CONTENT OF FRUIT JUICES CONTAINING PULP - A method for influencing the pulp content of a fruit or citrus juice. The method steps include: continuously purifying the juice of a pulp phase in a centrifugal field of a separator, the pulp being discharged from a drum of the separator through a pulp discharge line; measuring a density of the discharged pulp phase by a density flow-through measuring device; and, controlling a controllable device in accordance with a density measurement by the density flow-through measuring device thereby influencing the density of the pulp phase. | 2011-08-04 |
20110189360 | Method to Increase Solubility Limit of Rebaudioside D in an Aqueous Solution - Low pH beverage products which include rebaudioside D are provided. Methods of making low pH beverage products which include rebaudioside D are provided. Methods of making syrups which include rebaudioside D are provided. Methods of making supersaturated solutions of rebaudioside D are provided. | 2011-08-04 |
20110189361 | REJUVENATION OF USED COOKING OIL - Implements for decolorization, deodorization and deoxidization of used or filtered spent cooking oil are disclosed to improve on the service life of cooking oil and the health aspects of fried foods. This can be achieved on a small to large scale by simple implements filled with a mixture of plant-based granulated activated carbons and antioxidants, wherein the implements can be immersed in a frying appliance, such as a pot, a vat, a pan, a deep fryer and the like, containing used oil or in a storage unit of filtered oil. The overall safety, palatability and economics of a food preparation process are determined by the ease of oil containment and cleanup during and after frying with oil. | 2011-08-04 |
20110189362 | CONTROLLED BEVERAGE PRODUCTION DEVICE USING CENTRIFUGAL FORCES - The present invention relates to a beverage production device for preparing a liquid comestible from a portioned food substance contained in a sealed capsule. The device includes a centrifugal unit for receiving the sealed capsule, a driving mechanism connected to the centrifugal unit for enabling a rotational motion of the centrifugal unit, a liquid supply connected to the centrifugal unit, a flow rate or pressure measuring mechanism for the supplied liquid and a controller for controlling the rotational speed of the driving mechanism dependent on the measured flow rate or the measured pressure of the liquid. | 2011-08-04 |
20110189363 | CHERRY PITTER HAVING SAFETY AND CONVENIENCE - A safe and convenient cherry pitting device that includes a freestanding detachable base, a fruit support and pitter passthrough unit and a pitter containment cone. The unit is adapted for vertical mounting on the base. Further, the unit defines axially aligned top and bottom openings and one or more side openings. The pitter containment cone generally has a cone shaped outer surface including one or more walls defining a central cavity with a top closed end and a bottom open end for placement over the unit. The cone also includes a pitter bit that projects vertically downward within the top closed end of the cone in axial alignment with the top and bottom openings of the unit. | 2011-08-04 |